A case of coexistence of psoriasis vulgaris and lichen planus and a literature review.

Autor: Dobrev HP; Department of Dermatology and Venereology, Medical Faculty, Medical University, 15A V. Aprilov Blvd., 4002, Plovdiv, Bulgaria. hristo_dobrev@yahoo.com., Abadjieva TI; Department of Dermatology and Venereology, Medical Faculty, Medical University, 15A V. Aprilov Blvd., 4002, Plovdiv, Bulgaria., Ivanova ZG; Department of Dermatology and Venereology, Medical Faculty, Medical University, 15A V. Aprilov Blvd., 4002, Plovdiv, Bulgaria., Aleksiev TI; Department of Dermatology and Venereology, Medical Faculty, Medical University, 15A V. Aprilov Blvd., 4002, Plovdiv, Bulgaria., Vutova NI; Department of Dermatology and Venereology, Medical Faculty, Medical University, 15A V. Aprilov Blvd., 4002, Plovdiv, Bulgaria.

Publikováno v: Wiener medizinische Wochenschrift (1946) [Wien Med Wochenschr] 2024 Nov; Vol. 174 (15-16), pp. 328-331. Date of Electronic Publication: 2024 Jan 09.

Onychomadesis in a COVID-19 patient.

Autor: Ivanova ZG; Department of Dermatology and Venereology, Medical Faculty, Medical University, 15A V. Aprilov Blvd., 4002, Plovdiv, Bulgaria., Aleksiev TI; Department of Dermatology and Venereology, Medical Faculty, Medical University, 15A V. Aprilov Blvd., 4002, Plovdiv, Bulgaria., Dobrev HP; Department of Dermatology and Venereology, Medical Faculty, Medical University, 15A V. Aprilov Blvd., 4002, Plovdiv, Bulgaria. hristo_dobrev@yahoo.com.

Publikováno v: Wiener medizinische Wochenschrift (1946) [Wien Med Wochenschr] 2023 Sep; Vol. 173 (11-12), pp. 272-275. Date of Electronic Publication: 2022 Nov 28.

Remyelination varies between and within lesions in multiple sclerosis following bexarotene.

Autor: Brown JWL; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.; NMR Research Unit, Queen Square Multiple Sclerosis Centre, University College London (UCL) Queen Square Institute of Neurology, London, UK.; Clinical Outcomes Research Unit (CORe), University of Melbourne, Melbourne, Australia., Prados F; NMR Research Unit, Queen Square Multiple Sclerosis Centre, University College London (UCL) Queen Square Institute of Neurology, London, UK.; e-Health Center, Universitat Oberta de Catalunya, Barcelona, Spain.; Department of Medical Physics and Biomedical Engineering, Centre for Medical Image Computing, University College London, London, UK., Altmann DR; Medical Statistics Department, London School of Hygiene & Tropical Medicine, London, UK., Kanber B; NMR Research Unit, Queen Square Multiple Sclerosis Centre, University College London (UCL) Queen Square Institute of Neurology, London, UK.; Department of Medical Physics and Biomedical Engineering, Centre for Medical Image Computing, University College London, London, UK.; National Institute for Health Research Biomedical Research Centre, University College London Hospitals NHS Foundation Trust and University College London, London, UK., Stutters J; NMR Research Unit, Queen Square Multiple Sclerosis Centre, University College London (UCL) Queen Square Institute of Neurology, London, UK., Cunniffe NG; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK., Jones JL; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK., Georgieva ZG; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK., Needham EJ; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK., Daruwalla C; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK., Wheeler-Kingshott CG; NMR Research Unit, Queen Square Multiple Sclerosis Centre, University College London (UCL) Queen Square Institute of Neurology, London, UK.; Brain Connectivity Centre, IRCCS Mondino Foundation, Pavia, Italy.; Department of Brain and Behavioural Sciences, University of Pavia, Pavia, Italy., Connick P; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK., Chandran S; Centre for Clinical Brain Sciences, University of Edinburgh, Edinburgh, UK.; UK Dementia Research Institute, University of Edinburgh, Edinburgh, UK., Franklin R; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK.; Wellcome-MRC Cambridge Stem Cell Institute, University of Cambridge, Cambridge, UK., MacManus D; NMR Research Unit, Queen Square Multiple Sclerosis Centre, University College London (UCL) Queen Square Institute of Neurology, London, UK., Samson R; NMR Research Unit, Queen Square Multiple Sclerosis Centre, University College London (UCL) Queen Square Institute of Neurology, London, UK., Coles A; Department of Clinical Neurosciences, University of Cambridge, Cambridge, UK., Chard D; NMR Research Unit, Queen Square Multiple Sclerosis Centre, University College London (UCL) Queen Square Institute of Neurology, London, UK.; National Institute for Health Research Biomedical Research Centre, University College London Hospitals NHS Foundation Trust and University College London, London, UK.

Publikováno v: Annals of clinical and translational neurology [Ann Clin Transl Neurol] 2022 Oct; Vol. 9 (10), pp. 1626-1642. Date of Electronic Publication: 2022 Sep 17.

Keratinocyte growth factor impairs human thymic recovery from lymphopenia.

Autor: Coles AJ; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Azzopardi L; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Kousin-Ezewu O; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Mullay HK; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Thompson SA; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Jarvis L; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Davies J; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Howlett S; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Rainbow D; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Babar J; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Sadler TJ; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Brown JWL; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Needham E; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., May K; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Georgieva ZG; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Handel AE; Nuffield Department of Clinical Neurosciences and., Maio S; Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Deadman M; Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Rota I; Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Holländer G; Department of Paediatrics, University of Oxford, Oxford, United Kingdom., Dawson S; Cambridge Clinical Trials Unit, Cambridge University Hospitals NHS Foundation Trust, Cambridge, United Kingdom.; Medical Research Council (MRC) Biostatistics Unit, Cambridge Institute of Public Health, Cambridge, United Kingdom., Jayne D; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom., Seggewiss-Bernhardt R; University Hospital of Würzburg, Würzburg, Germany.; Department of Hematology/Oncology, Soziastiftung Bamberg, Bamberg, Germany., Douek DC; National Institute of Allergy and Infectious Diseases, NIH, Bethesda, Maryland, USA., Isaacs JD; Institute of Cellular Medicine, Newcastle University, and Musculoskeletal Unit, Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom., Jones JL; Department of Clinical Neurosciences, University of Cambridge, Cambridge, United Kingdom.

Publikováno v: JCI insight [JCI Insight] 2019 May 07; Vol. 5. Date of Electronic Publication: 2019 May 07.

Suppression of IL-12p40-related regulatory cytokines by suberoylanilide hydroxamic acid an inhibitor of histone deacetylases.

Autor: Dobreva ZG; a Department of Molecular Biology, Immunology and Medical Genetics, Medical Faculty , Trakia University , Bulgaria., Grigorov BG; a Department of Molecular Biology, Immunology and Medical Genetics, Medical Faculty , Trakia University , Bulgaria., Stanilova SA; a Department of Molecular Biology, Immunology and Medical Genetics, Medical Faculty , Trakia University , Bulgaria.

Publikováno v: Immunopharmacology and immunotoxicology [Immunopharmacol Immunotoxicol] 2016 Aug; Vol. 38 (4), pp. 281-5. Date of Electronic Publication: 2016 May 31.